Related Experiment Video
Updated: Jun 9, 2026
Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Quercetin Affects Carcinogenic Phenotype of Breast and Lung Cancer Cells Differentially Through Sterol Regulation
Isha Rakheja1,2, Vishal Bharti1, Vandana Singh1,2
1CSIR-Institute of Genomics & Integrative Biology, Delhi, India.
Abstract:
Targeting MALAT1 in cancer treatment is an attractive strategy due to the undebatable role of this lncRNA in the disease. Small molecules toward this noncoding RNA have, in fact, entered preclinical trials, without resulting in a robust demonstration in favor of their use in therapy. To test the robustness of this method, we asked how aspects of carcinogenesis get affected when knocking down MALAT1 in different cell lines. Using two such cell lines in this study to compare side-by-side, we observed that small molecule quercetin (and its subsequent reduction of MALAT1 lncRNA levels) showed heterogenic effects on carcinogenesis, which is similarly indicated by previous literature. Further, using a combination of cell biology (including the use of 3D tumor spheroids) and bioinformatics, this study is able to pinpoint the probable function of the SREBP1 protein (which showed a significant reduction of around 50%) in affecting carcinogenesis via MALAT1, corroborating earlier reports that link MALAT1 to the sterol regulation axis. This study, in summary, notes that using MALAT1 reduction (using quercetin or otherwise) needs to be very specific in the targeting of cancer cells in order to avoid paradoxical results.
Insights
Targeting MALAT1 long noncoding RNA (lncRNA) with quercetin shows varied effects on cancer development. Further research is needed to specifically target cancer cells and avoid unintended consequences.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The long noncoding RNA MALAT1 plays a significant role in cancer development.
- Therapeutic strategies targeting MALAT1 are under investigation, but their efficacy requires further validation.
- Quercetin, a small molecule, has been explored for its potential to reduce MALAT1 levels.
Purpose of the Study:
- To investigate the effects of MALAT1 knockdown on carcinogenesis using different cell lines.
- To explore the role of the protein SREBP1 in MALAT1-mediated carcinogenesis.
- To assess the therapeutic potential and specificity of targeting MALAT1 in cancer treatment.
Main Methods:
- Utilized two distinct cell lines to compare the effects of MALAT1 knockdown.
- Employed cell biology techniques, including 3D tumor spheroids.
- Integrated bioinformatics analysis to identify protein functions and pathways.
- Quantified the reduction of MALAT1 lncRNA and SREBP1 protein levels.
Main Results:
- Quercetin-induced reduction of MALAT1 exhibited heterogeneous effects on carcinogenesis across different cell lines.
- Observed a significant reduction (approximately 50%) in SREBP1 protein levels.
- Confirmed the link between MALAT1 and the sterol regulation axis through SREBP1.
- Demonstrated that MALAT1 knockdown can have paradoxical effects if not specifically targeted.
Conclusions:
- Targeting MALAT1 for cancer therapy requires highly specific approaches to avoid adverse outcomes.
- The interaction between MALAT1 and SREBP1 highlights a potential mechanism in sterol regulation relevant to cancer.
- Further studies are necessary to optimize MALAT1-targeted therapies for cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:34Inhibition of Cdk Activity